milohimself
RIP CITY
- Joined
- Sep 18, 2004
- Messages
- 48,891
- Likes
- 31
The polling here is from Kaiser Family Foundation (not associated with Kaiser Permanente), USA Today, etc. Not really controversial sources.I have a problem with this post, not so much with the post, but the data. It seems to me that everytime they go and do these test, they go to poor neighborhoods so they can pretty much swing any kind of data in their favor.(not a fact/my opinion) Did you guys get tested for any of the data that is shown above?
I don't think it's a question of incentive, it's a question of fastest development. When France, Switzerland, other countries that had reasonably large pharmaceutical industries switched to a cost control system, their R&D did slow some. Most of that production switched over to the US, but everybody else still collectively bargains for the drugs produced here.which is not my point (and you still don't know what they buy the drug for). What if there was no incentive to develop drugs like that?
I think it's safe to say that with patents and such in place, cost/accessibility and price of drugs share an inverse relationship. What you're bringing up is one end of the spectrum. What about the other?